Douglas Foerster
Overview
Explore the profile of Douglas Foerster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz-Manera J, Urtizberea J, Schey C, Kole A, von Gallwitz P, Whiting A, et al.
Neuromuscul Disord
. 2023 Jan;
33(2):208-217.
PMID: 36706619
Although mexiletine effectively treats myotonia, supply disruptions affected Europe between 2008-2018. MyoPath was a mixed-methods, cross-sectional, market research survey conducted January-June 2018 to evaluate consequences of limited access to/awareness of...
2.
Stein J, Haas J, Ong S, Borchert K, Hardt T, Lechat E, et al.
Clinicoecon Outcomes Res
. 2018 Feb;
10:93-103.
PMID: 29440920
Background: Iron-deficiency anemia and iron deficiency are common comorbidities associated with inflammatory bowel disease (IBD) resulting in impaired quality of life and high health care costs. Intravenous iron has shown...
3.
DHaese J, Ceyhan G, Demir I, Layer P, Uhl W, Lohr M, et al.
Pancreas
. 2014 Apr;
43(6):834-41.
PMID: 24717829
Objective: Exocrine pancreatic insufficiency (EPI) is frequent in patients with chronic pancreatitis (CP). This 1-year, prospective, multicenter, observational, disease management study aimed to assess symptom improvement and quality of life...
4.
Rotter J, Foerster D, Bridges J
Expert Rev Pharmacoecon Outcomes Res
. 2012 Dec;
12(6):711-23.
PMID: 23252354
Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of...
5.
Rautenberg T, Zerwes U, Foerster D, Aultman R
Clinicoecon Outcomes Res
. 2012 May;
4:109-16.
PMID: 22570557
Background: The safety and efficacy of racecadotril to treat acute watery diarrhea (AWD) in children is well established, however its cost effectiveness for infants and children in Europe has not...